BioSpace News Archive

FOXO BioScience today announced the completion of an agreement to bring DNA methylation-based testing services of laboratory mice to the scientific research community. FOXO collaborated with Van Andel

EOS imaging reschedules the publication of its results for the full year ended December 31, 2019. In the context of the COVID-19 health crisis, the Company has decided to postpone the date of publication of its annual result

Magellan Health, Inc. (NASDAQ: MGLN), one of the nation’s leaders in behavioral health, today announced that it has opened a free national 24-hour crisis line for all first responders and healthcare workers who are serving on the front lines battling the coronavirus pandemic.

Quanterix Corporation (NASDAQ: QTRX), a company revolutionizing digital biomarkers, joined forces with PPH in the fight against COVID-19

Adamas Pharmaceuticals, Inc. announced that the compensation committee of the company’s board of directors granted seven new employees the option to purchase an aggregate of 86,000 shares of the company’s common stock, at a per share exercise price of $2.84, the closing trading price on April 7, and restricted stock units to acquire 43,000 shares of the company’s common stock.

Dr. Christopher Murray, Director of the Institute for Health Metrics and Evaluation at the University of Washington’s School of Medicine, will host a press briefing on Saturday, April 11, at 11 am / 4 pm on the latest forecasts in the U.S., the U.K. and Europe regarding deaths and hospital usage related to COVID-19.

The demand in the global pta balloons catheter market is expected to increment at a healthy CAGR during the forecast period of 2020 to 2029, gaining traction from a number of factors such as rising percentage of geriatrics in the world population, the prevalence of target diseases, growing demand for early detection of incurable diseases, and the presentation of innovative applications.

The demand in the global radiation monitoring market is expected to increment at a healthy CAGR during the forecast period of 2020 to 2029, gaining traction from a number of factors such as rising percentage of geriatrics in the world population, the prevalence of target diseases, growing demand for early detection of incurable diseases, and the presentation of innovative applications.

The demand in the global radiofrequency ablation devices for pain market is expected to increment at a healthy CAGR during the forecast period of 2020 to 2029, gaining traction from a number of factors such as rising percentage of geriatrics in the world population, the prevalence of target diseases, growing demand for early detection of incurable diseases, and the presentation of innovative applications.

Therapeutic respiratory devices are meant for therapeutic usage to improve pulmonary function, boost lung oxygenation and aid mucus removal from bronchi during respiratory therapy.